Damora Therapeutics, Inc. (DMRA) stock
Close on Nov 13, 2026Market cap $1.34BP/E 5.4Yield 0.00%
Damora Therapeutics statistics
55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 2902.6%
- 10.8%
- Shares Change (QoQ)
- 0.28%
- 0.50%
- Float
- 51M
- 49M
- Shares Held by Insiders
- 17.6%
- 11.7%
- Shares Held by Institutions
- 105.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- -8.98%
- -0.80%
- Short % of Float
- 9.22%
- 9.01%
- Short % of Shares Outstanding
- 7.60%
- 6.30%
- Days to Cover
- 10.66
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $38.33
- –
- 52-Week Low
- $15.76
- –
- 20-Day Moving Average
- $22.00
- –
- 50-Day Moving Average
- $22.19
- –
- 200-Day Moving Average
- $25.49
- –
- Average True Range (14)
- $1.72
- –
- Price Change (1 Week)
- -8.86%
- -1.15%
- Price Change (1 Month)
- 15.3%
- -4.87%
- Price Change (3 Months)
- -30.5%
- -21.0%
- Price Change (6 Months)
- -12.2%
- -20.6%
- Price Change (YTD)
- -6.13%
- -23.6%
- Price Change (1 Year)
- -8.47%
- -22.4%
- Price Change (3 Years)
- 44.0%
- -29.5%
- Price Change (5 Years)
- -75.7%
- -77.9%
- Average Volume (10 Days)
- 557,274
- –
- Average Volume (20 Days)
- 482,057
- –
- Average Volume (90 Days)
- 512,001
- –
- Relative Volume
- 0.92
- 0.70
- Relative Strength Index (14)
- 46.8
- 43.4
- Volatility (1 Year)
- 99.3%
- 80.1%
- Beta (5 Years)
- 0.88
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -116.1%
- -49.9%
- Return on Assets (ROA)
- -107.4%
- -40.6%
- Return on Capital Employed (ROCE)
- -61.3%
- -37.9%
Financial positionIndustry
- Current Ratio
- 14.80
- 3.30
- Quick Ratio
- 14.72
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$41.67M
- -$689.41K
- Employee Count
- 7
- 74
Income statement (TTM)Industry
- Pretax Income
- -$291.34M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $528.48M
- $17.76M
- Net Cash Per Share
- $8.56
- $0.80
- Equity (Book Value)
- $495.76M
- $53.89M
- Book Value Per Share
- $8.03
- $1.50
- Tangible Book Value
- $495.76M
- $27.13M
- Working Capital
- $495.43M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Dividend Per Share
- $0.00
- $0.83
- Years of Dividend Growth
- 0
- 0
Taxes and interestIndustry
- Income Tax
- $341.00K
- $73.00K
Scores and fair valueIndustry
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | DMRA | S&P 500 | Difference | DMRA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +16.4% | -3.0% | +19.4 pts | ||
| 3 months | -29.7% | -2.8% | −26.9 pts | ||
| Year to date | -6.1% | +11.5% | −17.6 pts | ||
| 1 year | -22.4% | +13.5% | −35.9 pts | ||
| 3 years | +50.3% | +77.7% | −27.4 pts | +14.5% | +21.1% |
| 5 years | -75.7% | +72.6% | −148.3 pts | -24.6% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M DMRA shares were sold short on Oct 30, 2026, down 9.0% from the previous report, or 9.22% of the shares available to trade. At recent volumes it would take 10.7 days to buy them back. Over the last 20 sessions, 61.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,689,717 | -9.0% | 439,761 | 10.7 |
| Oct 15, 2026 | 5,152,194 | +8.9% | 461,896 | 11.2 |
| Sep 30, 2026 | 4,733,297 | +0.0% | 985,492 | 4.8 |
| Sep 15, 2026 | 4,732,463 | +14.5% | 552,562 | 8.6 |
| Aug 31, 2026 | 4,131,367 | -12.8% | 311,356 | 13.3 |
| Aug 14, 2026 | 4,739,939 | -3.1% | 349,370 | 13.6 |
| Jul 31, 2026 | 4,893,454 | +4.4% | 417,727 | 11.7 |
| Jul 15, 2026 | 4,688,241 | +31.4% | 580,045 | 8.1 |
| Jun 30, 2026 | 3,567,900 | +172.3% | 1,355,663 | 2.6 |
| Jun 15, 2026 | 1,310,364 | -6.6% | 389,269 | 3.4 |
| May 29, 2026 | 1,402,988 | +8.7% | 338,844 | 4.1 |
| May 15, 2026 | 1,290,741 | +8.4% | 418,102 | 3.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?